Medtronic received information via a journal article that six patients with a hancock bioprosthetic valved conduit underwent a post-implant balloon dilatation due to conduit stenosis.The patients were included in a retrospective chart review of 38 patients from a single medical facility who received right-ventricle-to-pulmonary-artery (rv-to-pa) valved conduits over a 127-month period.The article compared the results of a specific non-medtronic manufacturer¿s device with five different types or models of devices.Patient information was de-identified as part of the study, and the information of the five device types/models was aggregated and no detailed information regarding the medtronic devices/patient issues/outcomes could be determined from the article¿s content.The article did note that there was a 31.6% success rate with the balloon dilatations for the five-device group.The article also noted that some patients whose balloon dilatations were not successful did not undergo reoperation, and that some patients whose balloon dilatations were successful underwent reoperation for other factors.No significant complications associated with the balloon dilation procedures were reported.The media age of the patient population in the study was seven years (range: 26 months to 32 years) and the median weight was 21.3 kg (range: 12.5-101.8 kg).
|
An attempt to contact the article¿s lead/corresponding author via the hospital's pediatric department was unsuccessful.Additional efforts are being made to obtain additional information.Without device- or patient-identifying information, it could not be determined if reports have previously been received on any of the six patients in this study article.(b)(4).Percutaneous balloon dilation of carpentier-edwards porcine-valved right ventricle-to-pulmonary artery conduits authors: amanda c.Hall, daniel e.Miga, glenn t.Leonard, hongyue wang, rae-ellen kavey, george m.Alfieris published: december 11, 2012 pediatric cardiology (2013) 34:978¿983 doi 10.1007/s00246-012-0591-2.
|